Faculty Disclosures
| Barbara C. Jobst, MD, PhD, FAAN |
Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from Harvard Pilgrim. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC. |
| Danielle M. Andrade, MD |
Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zodiac. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke therapeutics. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. |
| Samantha Schmidt |
No disclosure on file
|
| William O. Tatum IV, DO, FAAN |
Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities. |
| Dennis J. Dlugos, MD |
Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium. |
| Sanjeev V. Kothare, MD, FAAN |
Dr. Kothare has nothing to disclose. |
| Steven C. Schachter, MD, FAAN |
Dr. Schachter has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Schachter has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Schachter has received intellectual property interests from a discovery or technology relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care. |
|
No disclosure on file
|
| Catherine Phillips, MD |
No disclosure on file
|
| Shefali Karkare, MD |
Dr. Karkare has nothing to disclose. |
| Felicia Chu, MD |
No disclosure on file
|
| Anteneh M. Feyissa, MD, MSc, FAAN |
Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. |
| Jay Gavvala, MD |
The institution of Dr. Gavvala has received research support from NIH. |
| Jennifer G. Chu, MD |
No disclosure on file
|
| Steven S. Rosenfeld, MD, PhD |
No disclosure on file
|
| Danielle A. Becker, MD |
Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. |
| Trudy Pang, MD |
Dr. Pang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stratus an Alliance Company. |
| Lucretia Long, DNP, APRN-CNP, FAES |
Mrs. Long has received personal compensation for serving as an employee of SKLife. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SKLife. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst Pharmaceutical. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Liva Nova. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK lIFE. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Liva Nova. |
| Nilufer Taner, MD, PhD, FAAN |
The institution of Dr. Taner has received research support from NIH. |
| Mariet Allen, PhD |
No disclosure on file
|
| Atul Maheshwari, MD |
Dr. Maheshwari has nothing to disclose. |
| Alfredo Quinones-Hinojosa |
Alfredo Quinones-Hinojosa has nothing to disclose. |
| Jumana T. Alshaikh, MD |
Dr. Alshaikh has nothing to disclose. |
| Nancy Santilli, RN, PNP, MN |
No disclosure on file
|
| Jannis R. Brea |
No disclosure on file
|
| Mohamad Koubeissi, MD, FAAN |
Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. |
| Glenn Morrison, PhD |
Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has stock in Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care. |
| Fabio Nascimento, MD |
Dr. Nascimento has received publishing royalties from a publication relating to health care. Dr. Nascimento has a non-compensated relationship as a Editorial Team Member with Neurology RFS that is relevant to AAN interests or activities. Dr. Nascimento has a non-compensated relationship as a Production Team with Neurology Podcast that is relevant to AAN interests or activities. |
| Elizabeth Gerard, MD |
Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care. |
| Gail M. Farfel, PhD |
Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Durect Corp. Dr. Farfel has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Zogenix. Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AvroBio. Dr. Farfel has received intellectual property interests from a discovery or technology relating to health care. |
| Taha Gholipour, MD |
Dr. Gholipour has nothing to disclose. |
| Naoum P. Issa, MD, PhD |
Dr. Issa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Issa has received stock or an ownership interest from Gilead. The institution of Dr. Issa has received research support from NIH. |
| Idelle Vaynberg |
No disclosure on file
|
| Lindsay Schommer, NP |
No disclosure on file
|
| Elaine T. Kiriakopoulos, MD |
The institution of Dr. Kiriakopoulos has received research support from Centers for Disease Control and Prevention. The institution of Dr. Kiriakopoulos has received research support from Department of Defense. The institution of Dr. Kiriakopoulos has received research support from Epilepsy Foundation New England. |
| Liana Theroux, MD |
Dr. Theroux has nothing to disclose. |
| Elizabeth Cunningham |
No disclosure on file
|
| Arnold Gammaitoni, PharmD |
Dr. Gammaitoni has received personal compensation for serving as an employee of Zogenix Inc.. Dr. Gammaitoni has received stock or an ownership interest from Zogenix Inc.. |